National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
About National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 28 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system.
By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world. World-renowned experts from NCCN Member Institutions diagnose and treat patients with a broad spectrum of cancers and are recognized for dealing with complex, aggressive, or rare cancers. NCCN Member Institutions pioneered the concept of the multidisciplinary team approach to patient care and conduct innovative research that contributes significantly to understanding, diagnosing, and treating cancer. NCCN programs offer access to expert physicians, superior treatment, and quality and safety initiatives that continuously improve the effectiveness and efficiency of cancer care globally.
NCCN 20th Anniversary Video - Improving Cancer Care Together
January 31, 2015 marked the 20th anniversary of the National Comprehensive Cancer Network; originally announced as an alliance of 13 leading cancer centers in 1995, NCCN has grown to a network of 26 academic cancer centers devoted to patient care, research, and education.
Featuring past and present leadership, this video describes the groundbreaking accomplishments of NCCN over the past two decades that have improved the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.
76 articles with National Comprehensive Cancer Network
New agreement between National Comprehensive Cancer Network and Syapse will augment health information technology around cancer care
NCCN Awarded $2 Million in Research Funding from Taiho Oncology to Study Trifluridine and Tipiracil in Various Cancers
The National Comprehensive Cancer Network's Oncology Research Program received a grant to investigate effectiveness of trifluridine and tipiracil for treatment of people with colorectal, gastric, and other cancers
Updated Breast Cancer Resources and Events from NCCN Keep Patients and Doctors Worldwide Informed during Breast Cancer Awareness Month
Latest metastatic breast cancer treatment options to be explained in webinar for patients and loved ones, corresponding with updated patient guidelines, on October 22 and 29
New NCCN Guidelines for Patients: NET provides background and treatment information for the type of cancer experienced by Aretha Franklin and Steve Jobs
National Blood Cancer Experts Provide Updates on CAR T-Cell Therapy, Leukemia, Lymphoma, and Myeloma; New NCCN Guidelines for Systemic Mastocytosis Now Available
The NCCN 13th Annual Congress: Hematologic Malignancies™ examines novel treatments, major milestones, and challenging case studies for hematologic oncology. Join the conversation online with the hashtag #NCCNhem18.
NCCN Summit Explores How Current Health Policies Help and/or Hinder the Coordination of High-Quality Cancer Care Delivery in the U.S.
National Comprehensive Cancer Network convenes Policy Summit to address changing care paradigms, and the impact across the cancer care continuum
The National Comprehensive Cancer Network® (NCCN®) has released new treatment guidelines for a group of rare cancers that impact women during pregnancy.
New, Reliable Source of Free Information for People with Liver, Gallbladder, or Bile Duct Cancer, Offered by NCCN
National Comprehensive Cancer Network releases new patient guidelines for hepatobiliary cancers, sponsored by the Global Liver Institute.
A new study published in JNCCN - Journal of the National Comprehensive Cancer Network finds that cancer care costs in the United States are higher for people under age 65, and the costs increase with disease stage.
National Comprehensive Cancer Network® (NCCN®) engages Envision Pharma Group to support their Oncology Research Program using iEnvision - a new web-based software platform for medical programs
The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced the selection and implementation of the iEnvision medical affairs platform developed by Envision Technology Solutions.
NovoCure Release: National Comprehensive Cancer Network Guidelines Recommend Optune As A Standard Treatment Option For Newly Diagnosed Glioblastoma
New National Comprehensive Cancer Network Guidelines Include Evidence Blocks To Illustrate Value In Breast, Colon, Kidney, And Rectal Cancers
National Comprehensive Cancer Network Awarded $2 Million In Research Funding From Infinity Pharmaceuticals Inc. To Study Duvelisib In Hematologic Malignancies
National Comprehensive Cancer Network Awards Research Grants To Five Investigators To Study Effectiveness Of Enzalutamide In Various Cancers
Peregrine And National Comprehensive Cancer Network (NCCN) Form Clinical Collaboration To Evaluate Novel Cancer Treatment Combinations With Bavituximab
Myriad Genetics, Inc. Release: National Comprehensive Cancer Network Updates Guidelines For Hereditary Colon Cancer Testing
Researchers Receive Grants From National Comprehensive Cancer Network Oncology Research Program Funded Through AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.)/Astellas Pharma Inc. Collaboration
Researchers Receive Grants From National Comprehensive Cancer Network Oncology Research Program Funded Through GlaxoSmithKline
Researchers Receive Grants From National Comprehensive Cancer Network Oncology Research Program Funded Through Boehringer Ingelheim Corporation